Anaplasma phagocytophilum, the causative agent of human granulocytic anaplasmosis, is an obligate intracellular bacterium that infects neutrophils and neutrophil precursors. Bacterial recognition of P-selectin glycoprotein ligand-1 (PSGL-1) and the ␣2,3-sialylated-and ␣1,3-fucosylated-moiety sialyl-Lewis x (sLe x ), which modifies the PSGL-1 N terminus, is important for adhesion to and invasion of myeloid cells. We have previously demonstrated that A. phagocytophilum organisms of the NCH-1 strain that utilize an sLe x -modified PSGL-1-independent means of entry can be enriched for by cultivation in undersialylated HL-60 cells that are unable to construct sLe x . Because it was unknown whether other A. phagocytophilum isolates share this ability, we extended our studies to the geographically diverse strains HZ and HGE1. HL-60 A2 is a clonal cell line that is defective for sialylation and ␣1,3-fucosyltransferase. HL-60 A2 cell surfaces, therefore, not only lack sLe x but also are virtually devoid of any other sialic acid-and/or ␣1,3-fucose-modified glycan. By cultivating HZ and HGE1 in HL-60 A2 cells, we enriched for bacterial subpopulations (termed HZA2 and HGE1A2) that bind and/or infect myeloid cells in the absence of sialic acid and ␣1,3-fucose and in the presence of antibody that blocks the N terminus of PSGL-1. Thus, multiple A. phagocytophilum isolates share the ability to use sLe xmodified PSGL-1-dependent and -independent routes of entry into myeloid cells. HZA2 and HGE1A2 represent enriched bacterial populations that will aid dissection of the complexities of the interactions between A. phagocytophilum and host myeloid cells.
Anaplasma phagocytophilum is the etiologic agent of human granulocytic anaplasmosis, a debilitating and potentially deadly tick-transmitted infection emerging in the United States, Europe, and Asia. The bacterium is also an important veterinary pathogen, causing disease in dogs, sheep, and horses. Clinical symptoms associated with A. phagocytophilum infection include fever, headache, and myalgia. More distinguishing manifestations include leucopenia, thrombocytopenia, and elevated levels of serum hepatic transaminases (3, 6) . Within its mammalian host, A. phagocytophilum invades vascular endothelial cells and neutrophils (8) , and the invasion of neutrophils is a hallmark of this unusual obligate intracellular pathogen (3, 6, 14) . A. phagocytophilum infection of neutrophils and neutrophil precursors is linked to bacterial recognition of Pselectin glycoprotein ligand-1 (PSGL-1), which is expressed at high densities on myeloid cell surfaces, and sialyl-Lewis x (sLe x ), a tetrasaccharide that modifies the N termini of PSGL-1 and other selectin ligands (7, 9, 11, 13) . The known determinants crucial for bacterial binding are ␣2,3-sialic acid, ␣1,3-fucose of sLe x , and the primary amino acid sequence of the PSGL-1 N terminus (9, 13, 18) .
Bacterial adhesion and invasion are complex, often multifactorial processes, and many intracellular pathogens can utilize more than one route of entry. We have recently demonstrated this to be true for the A. phagocytophilum NCH-1 strain (13) . Treatments that disrupt A. phagocytophilum interaction with one or more of the known determinants required for adhesion result in various degrees of inhibition but never the abolition of binding or entry (2, 7, 9, 18) . We reasoned that A. phagocytophilum likely recognizes at least one additional sLe x -and/or PSGL-1-independent receptor. By cultivating NCH-1 in HL-60 sLe x(Ϫ/low) cells, which are severely undersialylated and consequently cannot construct sLe x , we enriched for the subpopulation of NCH-1 organisms (termed NCH-1A) capable of sLe x -independent infection. NCH-1A consequently exhibits a lessened dependence on PSGL-1 (13).
NCH-1 was recovered from a patient in Massachusetts (10). It is unknown whether the ability to use one or more sLe x -independent receptors is unique to NCH-1 or is shared by other A. phagocytophilum isolates. We, therefore, extended our studies to A. phagocytophilum strains HZ (15) and HGE1 (5), which were isolated from patients in New York and California, respectively. By cultivating HZ and HGE1 in a clonal HL-60 cell line devoid of sialylated and ␣1,3-fucosylated glycans (HL-60 A2) (7, 13), we successfully enriched for bacteria able to propagate in the absence of these determinants. The selected subpopulations, named HZA2 and HGE1A2, are also less dependent on PSGL-1 for adhesion. This study (i) demonstrates that numerous A. phagocytophilum strains possess the ability to engage multiple receptors for adhesion and entry and (ii) represents an important first step toward identifying the bacterial and host factors involved in the sLe x -modified PSGL-1-independent route of entry. Enrichment for HGE1A2 and HZA2 bacteria. HZ and HGE1 were cultivated in HL-60 sLe x(Ϫ/low) cells to enrich for bacteria with lessened dependencies on sialic acid (13) . To further enrich for sLe x -independent bacteria, host cell-free sialic acid-independent organisms recovered from 1.0 ϫ 10 6 infected HL-60 sLe x(Ϫ/low) cells were inoculated into 1.0 ϫ 10 6 sialic acid-deficient and ␣1,3-fucosyltransferase-defective HL-60 A2 cells (7, 13) (provided by Ulrike Munderloh and Curtis Nelson of the University of Minnesota). By the second passage, the percentages of HZ-or HGE1-infected cells exceeded 90%. The A. phagocytophilum populations able to propagate infection in HL-60 A2 cells were named HZA2 and HGE1A2.
MATERIALS AND METHODS

In
Assessment of A. phagocytophilum binding and infection. Host cell-free A. phagocytophilum organisms were added to 0.25 ϫ 10 6 HL-60 or HL-60 A2 cells in Iscove's modified Dulbecco's Eagle medium (IMDM; Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (IMDM-10). In some experiments, incubations were performed in the presence of 10 g/ml KPL1 (BD Pharmingen, San Diego, CA) (16), which is a monoclonal antibody (MAb) that blocks A. phagocytophilum's access to the PSGL-1 N terminus (9, 13), or isotypematched murine immunoglobulin G1 (IgG1). Following incubation for 30 min at 25°C, the cells were washed twice with phosphate-buffered saline and centrifuged at 300 ϫ g for 5 min to remove unbound bacteria. The cells were resuspended in phosphate-buffered saline, transferred to the wells of Teflon-coated slides (Carlson Scientific, Peotone, IL), and examined by immunofluorescence microscopy using rabbit polyclonal anti-A. phagocytophilum antiserum followed by Alexafluor 488-conjugated goat anti-rabbit IgG (Invitrogen) as described in reference 1. To assess infection, the cells were resuspended in 1 ml IMDM-10 following the removal of unbound bacteria and cultivated at 37°C in 5% CO 2 for 72 h. At 24-h intervals postinfection, the host cells were examined for the presence of morulae, or intracytoplasmic A. phagocytophilum inclusions, by light microscopic examination of cytofuged samples. A total of 3.5 ϫ 10 4 A. phagocytophilum-infected host cells in 200 l IMDM-10 were cytofuged at 70 ϫ g for 2 min using a Cytospin 4 centrifuge (Thermo Electron, Pittsburgh, PA), fixed, and stained using Protocol Hema 3 reagents (ThermoFisher Scientific, Waltham, MA).
Statistical analyses. Student's t test (unpaired and two-tailed), performed using the Prism 4.0 software package (Graphpad, San Diego, CA), was used to assess statistical significance. Significance was set at a P of Ͻ0.05.
RESULTS
A. phagocytophilum HZA2 and HGE1A2 efficiently bind host myeloid cells lacking sialic acid and ␣1,3-fucose. To determine whether the ability to use one or more sLe x -independent receptors is unique to NCH-1 (13) or extends to other A. phagocytophilum isolates, we assessed HZ and HGE1. These strains were first cultivated in HL-60 sLe x(Ϫ/low) cells to enrich for sialic acid-independent organisms (13). To further enrich for sLe x -independent bacteria, the derived populations were transferred to the clonal cell line HL-60 A2, which is sialylation defective and fails to transcribe fuc-TVII, the primary ␣1,3-fucosyltransferase required for sLe x construction (7, 13). HL-60 A2 cell surfaces, therefore, not only lack sLe x but also are virtually devoid of sialic acid-and/or ␣1,3-fucose-modified glycans. The selected populations were termed HZA2 and HGE1A2. We compared the efficiencies of HZA2 and HGE1A2 binding to HL-60 A2 cells with those of their HZ and HGE1 parental counterparts. HZ and HZA2 bound to HL-60 cells in comparable percentages, while HZA2 bound to a considerably greater number of HL-60 A2 cells than HZ on November 11, 2017 by guest http://iai.asm.org/ (Fig. 1A) . Significantly greater numbers of HZA2 than HZ organisms adhered to both HL-60 and HL-60 A2 cells (Fig.  1B) . Similar results were observed for HGE1 and HGE1A2, though the disparity between the numbers of HGE1 and HGE1A2 organisms bound to HL-60 A2 cells was severalfold greater than the disparity between the numbers of HZ and HZA2 organisms (Fig. 1C and D) . HZA2 and HGE1A2 binding to HL-60 A2 cells was less efficient than that to HL-60 cells. Thus, while HZA2 and HGE1A2 bind most effectively to cell surfaces presenting sialic acid and ␣1,3-fucose, their dependencies on such residues for adherence are strongly diminished relative to those of HZ and HGE1. A. phagocytophilum HZA2 and HGE1A2 are less dependent on sialic acid and ␣1,3-fucose for infection than HZ and HGE1, respectively. A. phagocytophilum recognition of sLe x is an important step that precedes internalization into myeloid cells (7, 18) . The propagation of HZA2 and HGE1A2 in HL-60 A2 cells suggests that these bacteria are able to invade by a route that does not depend on ␣2,3-sialic acid and ␣1,3-fucose. To directly assess the efficacies of HZA2 and HGE1A2 internalization, host cell-free HZ, HZA2, HGE1, and HGE1A2 organisms were incubated with HL-60 or HL-60 A2 cultures. At 24-h intervals, host cells were monitored for morula development as an indication of bacterial entry and replication. The kinetics of HZA2 infection of HL-60 cells proceeded more rapidly than that of HZ, as higher percentages of cells with HZA2 morulae were observed for all time points ( Fig. 2A) , significantly more HZA2 morulae per cell were detected at 96 and 120 h (Fig. 2B) , and HZA2-infected cultures were lysed by 144 h, whereas HZ-infected cultures were not. The observed disparities between HZ and HZA2 infection were considerably more pronounced for HL-60 A2 cells (Fig.  2C and D) . HZ infected a maximum of only 14% of HL-60 A2 cells by 96 h, and then their infection waned, while HZA2 infection reached 65% by 144 h. As much as 36-fold-more bacterial inclusions were detected in HZA2-infected HL-60 A2 cells than in HZ-infected HL-60 A2 cells. HGE1 and HGE1A2 exhibited similar rates of infection in HL-60 cells (Fig. 3A and  B) , while huge disparities between HGE1-and HGE1A2-infected HL-60 A2 cells were observed for all time points ( A. phagocytophilum HZA2 and HGE1A2 are less dependent on PSGL-1 for cellular adherence. PSGL-1 is an important receptor for A. phagocytophilum adhesion to human myeloid cells. Antibodies targeting the PSGL-1 N terminus can block this event (9, 13) . In addition to lowering the dependency of NCH-1A organisms on sLe x , cultivation in HL-60 sLe x(Ϫ/low) cells also enriches for PSGL-1-independent binding (9, 13). To determine whether enrichment of HZA2 and HGE1A2 bacteria in HL-60 A2 cells also selects for PSGL-1-independent binding, these strains, HZ, or HGE1 was incubated with HL-60 cells in the presence of the PSGL-1 N-terminus-targeting MAb KPL1 (16) or an isotype control. KPL1 drastically reduced HZ and HGE1 binding to HL-60 cells, though HGE1 binding was more pronounced (Fig. 4) . This is in agreement with our (13) and Herron and colleagues' (9) previous reports that HGE1 is heavily restricted in its dependence on PSGL-1. HZA2 bound to 2.5-fold-more KPL1-treated cells than HZ, while HGE1A2 bound to 7.7-fold-more KPL1-treated cells than HGE1. These results demonstrate that HZA2 and HGE1A2 bacteria have lessened dependencies on PSGL-1 for adherence but that optimal binding occurs in PSGL-1's presence.
DISCUSSION
This study demonstrates that geographically diverse and possibly all A. phagocytophilum strains can infect human myeloid cells using sLe x -modified PSGL-1 and/or at least one unknown receptor. The binding of A. phagocytophilum to PSGL-1 initiates a Syk-and ROCK1-dependent signaling cascade that promotes bacterial uptake (17) . Whether engagement of the sLe x -or PSGL-1-independent receptor initiates this or a separate signaling and entry pathway is unknown. NCH-1A, HZA2, and HGE1A2 are model organisms for investigating the signaling events associated with PSGL-1-independent entry.
Because A. phagocytophilum recognition of human sLe xmodified PSGL-1 leads to productive infection (7, 9, 13) and because inhibiting PSGL-1-mediated signaling nearly abolishes the infection of human myeloid cells (17) , an important question arises as to the relevance of entry through a different receptor. The answer may lie in the receptors utilized by the bacterium to invade its natural mammalian reservoir, the mouse. The binding of A. phagocytophilum to murine neutrophils occurs optimally through the recognition of sialic acid and absolutely requires ␣1,3-fucose (2). Remarkably, binding to and infection of murine neutrophils does not require PSGL-1. In fact, A. phagocytophilum cannot even bind to murine PSGL-1 because it lacks a critical peptide sequence found in the human PSGL-1 N terminus (18) . This stereospecific difference necessitates that A. phagocytophilum utilize a PSGL-1-independent receptor to invade murine neutrophils. Perhaps NCH-1A, HZA2, and HGE1A2 represent A. phagocytophilum organisms exhibiting upregulated expression of the adhesin required for infecting murine neutrophils. This adhesin would presumably not recognize murine PSGL-1 but would recognize a separate receptor and may function in cooperation with one or more adhesins recognizing sialylated and ␣1,3-fucosylated glycans (such as sLe x ) on the surfaces of murine neutrophils. This adhesin might recognize the same or a structurally similar receptor on human myeloid cells, which would account for the lessened dependence of NCH-1A, HZA2, and HGE1A2 on sLe x -modified PSGL-1. A. phagocytophilum infects vascular endothelial cells (8, 12) . It is hypothesized that such cells serve as the initial site of infection following tick transmission of A. phagocytophilum and/or serve as a reservoir for the bacterium once its presence in the peripheral bloodstream has waned. Endothelial cell line infection is enhanced following sialidase treatment (8) , which indicates that sialylated glycans are not utilized for invasion. Considering these data and those of this study and the fact that the bacterium naturally infects mice and several other mammals (3, 6) , it is conceivable that A. phagocytophilum possesses a veritable "Swiss army knife" of sLe x -independent adhesins that are either endothelial cell or host myeloid cell specific. These may be used in conjunction with or independently of sLe x -specific adhesins to invade myeloid and endothelial cells within A. phagocytophilum's various mammalian hosts.
The HZ genome has been sequenced (4) . sLe x -modified PSGL-1-independent binding by HZA2 (and HGE1A2 and NCH-1A) may be attributable to upregulated expression of an otherwise underexpressed adhesin. However, the phenotype of these organisms is equally consistent with down-regulation of one or more genes encoding sLe x -and/or PSGL-1-targeting adhesins such that sLe x -and PSGL-1-independent binding becomes more apparent. Indeed, NCH-1A binding to microspheres coated with a glycosulfopeptide mimicking the sLe xmodified PSGL-1 N terminus is reduced relative to that of NCH-1 and HGE1 (13) . Nonetheless, HZA2 represents an effective tool that can be used to identify genes that are unique to HZA2 or are differentially expressed between HZ and HZA2. We cannot exclude the possibility that sLe x -and PSGL-1-independent binding may be afforded by altered posttranslational modification of a preexisting adhesin. Regardless, HZA2, HGE1A2, and NCH-1A are enriched subpopulations of naturally occurring organisms that will prove useful for dissecting the adhesin repertoire used by A. phagocytophilum to infect myeloid cells.
